Form 4 Tracker
Martine A Rothblatt

Director; Director, Chairperson & CEO · 165 filings · Latest: Oct 15, 2026

BETA Technologies, Inc.
UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 7, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 6, 2026
Sale
$525.369,500$5.0M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 6, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 5, 2026
Sale
$518.749,500$4.9M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 5, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 4, 2026
Sale
$517.099,500$4.9M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 4, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 3, 2026
Sale
$516.069,500$4.9M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOAug 3, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
MARTINE ROTHBLATT—Aug 3, 2026
Proposed Sale
$517.71199,500$103.3M—
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 31, 2026
Sale
$518.969,500$4.9M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 31, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 30, 2026
Sale
$524.909,500$5.0M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 30, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 29, 2026
Sale
$522.379,500$5.0M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 29, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 28, 2026
Sale
$526.739,500$5.0M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 28, 2026
Option Exercise
$135.429,500$1.3M333,943
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 27, 2026
Sale
$530.429,500$5.0M324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 27, 2026
Option Exercise
$135.429,500$1.3M333,943